Sunshine Lake Pharma Co., Ltd.

This study is testing a new targeted drug called crifortinib besylate (taken as a pill) combined with standard chemotherapy in adults who have just been diagnosed with acute myeloid leukemia (AML). The trial has two phases: first, finding the best dose, then testing it in a large…

This study tests a new drug called HEC73543 (Clifutinib) against standard chemotherapy in 324 adults with a specific type of acute myeloid leukemia (FLT3-ITD) that has come back or not responded to first treatment. The goal is to see if the new drug helps people live longer and a…

This study tests a new oral drug called HEC169096 in people with advanced solid tumors, including thyroid cancer and non-small cell lung cancer, that have a specific RET gene change. The trial has two phases: the first finds the safest dose, and the second checks how well the dru…

This study tests two doses of HEC585 tablets against a placebo in 110 adults with progressive fibrosing interstitial lung disease, a condition where lung tissue scars and worsens over time. Participants take the drug or placebo daily for 24 weeks, with an optional extension up to…

This Phase 3 trial tests a new drug called HEC585, taken once daily, to see if it can slow lung function decline in people with idiopathic pulmonary fibrosis (IPF), a serious lung-scarring disease. About 472 adults aged 40 to 80 will be randomly assigned to receive HEC585, a plac…

This study tests a new drug called mitizodone phosphate in 600 adults with major depression. The goal is to see if it reduces depression symptoms better than a placebo over 8 weeks. The trial has two phases: first to find the best dose, then to confirm how well it works and if it…

This early-phase study tests the safety and how the body handles a new injection called HEC-007. It involves 126 healthy adults and overweight or obese individuals. Researchers will monitor side effects, measure drug levels in the blood, and check changes in weight and other heal…

This early-stage study is testing a single dose of an experimental injection called HEC-151 in healthy Chinese men aged 18 to 45. The main goal is to see if it is safe and how the body processes it. Participants will be closely monitored for side effects and changes in vital sign…

This early-stage study tests an experimental drug called HEC169584 in 96 healthy adults aged 18 to 45. The main goal is to check if the drug is safe and how the body processes it, not to treat any disease. Results will help guide future studies for non-alcoholic steatohepatitis (…